Stoke Therapeutics (STOK)
(Real Time Quote from BATS)
$12.40 USD
+0.14 (1.14%)
Updated Sep 27, 2024 12:16 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Earnings News For STOK
-
Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates
-
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
-
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
-
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
-
Earnings Preview: Stoke Therapeutics, Inc. (STOK) Q1 Earnings Expected to Decline
-
Stoke Therapeutics, Inc. (STOK) Reports Q4 Loss, Lags Revenue Estimates
-
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy?
-
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
-
Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Lags Revenue Estimates
-
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
-
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
-
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
-
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy?
-
Stoke Therapeutics, Inc. (STOK) Reports Q4 Loss, Tops Revenue Estimates
-
Stoke Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
-
Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates
-
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
-
Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates